Trial intelligence / Profile preview

MMF for Highly Sensitized Kidney Transplant Candidates

NCT00446459Phase 2Completed

Sponsor
University of Washington
Start
Apr 2006
Primary completion
Nov 2008
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of mycophenolate mofetil in kidney failure (ESRD), sponsored by University of Washington. Started Apr 2006; status: completed.

02

Drugs

mycophenolate mofetil
03

Conditions

kidney failure (ESRD)

Beyond the preview

Go deeper on NCT00446459.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00446459.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call